Revenue Comparison
Chart: Revenue Comparison. Values in USD billions. In Q1 2026: Amgen 8.618, AstraZeneca 15.384.
Amgen vs AstraZeneca Net Worth and Market Cap
Amgen (AMGN) and AstraZeneca (AZN) are peers in GLP-1. Amgen reported revenue of $8.6B as of Q1 2026, compared with $15.4B for AstraZeneca. AstraZeneca leads on revenue.
Amgen's gross margin is 68.2% versus 83.6% for AstraZeneca. Amgen's net margin is 21.1% versus 16.3% for AstraZeneca.
Key differences
- Revenue growth on the same quarter a year earlier: AstraZeneca +6.4% (Q2 2026), Amgen +5.8% (Q1 2026).
- Amgen keeps more of its revenue as operating profit: a 30.9% operating margin, against 20.6% at AstraZeneca.
- Amgen's KPIs on Sterling include AMG 513 Obesity Discontinuation and Cash and Cash Equivalents.
- AstraZeneca's KPIs on Sterling include Alliance Revenue by Partnered Medicine (Quarterly) and AZD5004 + AZD6234 Trial Timeline: Oral GLP-1 + Oral Amylin.
Latest Quarter Comparison
Table: Latest Quarter Comparison. 15 rows across Metric, Amgen, AstraZeneca.| Metric | Amgen | AstraZeneca |
|---|---|---|
| Market Cap | - | - |
| Revenue | $8.62B | $15.38B |
| Cost of Revenue | $2.74B | $2.52B |
| Gross Profit | $5.87B | $12.86B |
| Operating Income | $2.67B | $3.16B |
| Net Income | $1.82B | $2.51B |
| R&D Expense | $1.72B | $4.05B |
| Earnings Per Share | $3.34 | $1.59 |
| Gross Margin | 68.2% | 83.6% |
| Operating Margin | 30.9% | 20.6% |
| Net Profit Margin | 21.1% | 16.3% |
| Free Cash Flow | $1.48B | $2.13B |
| Cumulative Free Cash Flow | $165.69B | $121.22B |
| Operating Cash Flow | $2.19B | $2.89B |
| Cash & Equivalents | $12.04B | $4.89B |